2027 Equity Research Summer Intern Program (PhD)
Location: New York
Salary Range: $135,000 (pro-rated for Summer)
Leerink Partners offers a ten-week Summer Intern program to PhD students who can intern with us for Summer 2027 and potentially return full time in July 2028 with a completed PhD. This is an opportunity to be part of a world-class Research team focused on the innovation economy in the Healthcare sector. This internship program allows individuals the unique opportunity to assist in the day-to-day responsibilities of full-time equity research professionals.
Primary Duties and Responsibilities:
- Collect, evaluate and apply statistical and financial data on the economy and financial markets, specifically with respect to researching common stocks within the healthcare industry.
- Analyze and synthesize researched data and presentation of trends and ideas regarding business opportunities and investment decision-making processes.
- Observe interviews with company executives and industry leaders to develop and maintain sources of information in preparation of analyses.
- Maintain company databases using spreadsheet and database software.
- Prepare reports, opinions, recommendations, and statistical data, financial statement modeling, for use in the formulation of the investment policies and/or recommendations of the firm.
Experience and Qualifications Required:
- Qualified candidates will be currently pursuing their PhD in pharmacology, molecular biology, physiology, biochemistry, or some directly relevant medical discipline
- Ability to intern full time during Summer 2027 and potentially start full time in July 2028 (PhD will have been completed by this time)
- Some healthcare exposure, either academically or job-related preferred
- Interest in the stock market and Healthcare equity investment research
- Experience building pro forma financial models including forecasting revenue, income statement, balance sheet and cash flow statement
- Must possess the ability to synthesize data and articulate findings through excellent written and oral presentation skills
About Leerink Partners:
As the leading investment bank to the healthcare and life science industries, we help our clients move healthcare forward. With differentiated sector knowledge, unrivaled expertise, and a complete suite of capital market and advisory solutions, we are the industry’s partner of choice. Leerink Partners is a member of FINRA/SIPC. For more information, please visit: www.leerink.com.
Equal Employment Opportunity:
Leerink Partners is an equal opportunity employer and is dedicated to expanding its commitments and investments to create a more diverse, equitable and inclusive company culture and innovation ecosystem. We are strongly committed to the values and policy of equal employment opportunity across our employment practices.
Actual starting base pay will be determined on skills, experience, and other non-discriminatory factors permitted by law. Total compensation may also include variable incentives, bonuses, benefits, and/or other perks, as outlined in any formal offer made.
Skills Required
- Currently pursuing a PhD in pharmacology, molecular biology, physiology, biochemistry, or a directly relevant medical discipline
- Available to intern full time during Summer 2027
- Potentially available to start full time in July 2028 after completing the PhD
- Interest in the stock market and healthcare equity investment research
- Experience building pro forma financial models, including revenue, income statement, balance sheet, and cash flow forecasting
- Ability to synthesize data and articulate findings through excellent written and oral presentation skills
- Healthcare exposure through academic or job-related experience
What We Do
Leerink Partners is a leading investment bank providing a complete suite of financial solutions comprising M&A advisory, equity, debt, and derivative capital markets, equity research, and sales and trading capabilities. The firm’s strategic focus on the healthcare industry empowers it to provide unique advice and insights to its clients. The firm is a broker-dealer registered with the United States Securities and Exchange Commission and a member of the Financial Industry Regulatory Authority. SVB Securities LLC is doing business as Leerink Partners.
.jpg)
